Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Information about the 2019 Novel Coronavirus
AN EVALUATION OF RESTLESS LEGS SYNDROME SYMPTOM AUGMENTATION IN SUBJECTS TREATED WITH GABAPENTIN ENACARBIL FOR 12 WEEKS: SECONDARY INTEGRATED ANALYSES FROM TWO STUDIES Bogan, R. K., Ellenbogen, A. L., Ball, E., Ondo, W., Kushida, C., Williams, N. J., Caivano, C. AMER ACAD SLEEP MEDICINE. 2010: A264
View details for Web of Science ID 000208208001275